rs878855039

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001164760.2(PRKAR1B):​c.-83G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000637 in 1,325,432 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00067 ( 1 hom. )

Consequence

PRKAR1B
NM_001164760.2 5_prime_UTR_premature_start_codon_gain

Scores

3
4
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 1.60

Publications

3 publications found
Variant links:
Genes affected
PRKAR1B (HGNC:9390): (protein kinase cAMP-dependent type I regulatory subunit beta) The protein encoded by this gene is a regulatory subunit of cyclic AMP-dependent protein kinase A (PKA), which is involved in the signaling pathway of the second messenger cAMP. Two regulatory and two catalytic subunits form the PKA holoenzyme, disbands after cAMP binding. The holoenzyme is involved in many cellular events, including ion transport, metabolism, and transcription. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2015]
DNAAF5 (HGNC:26013): (dynein axonemal assembly factor 5) The protein encoded by this gene is essential for the preassembly or stability of axonemal dynein arms, and is found only in organisms with motile cilia and flagella. Mutations in this gene are associated with primary ciliary dyskinesia-18, a disorder characterized by abnormalities of motile cilia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2013]
DNAAF5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 18
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1319184).
BS2
High AC in GnomAd4 at 60 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001164760.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAR1B
NM_001164760.2
MANE Select
c.-83G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 11NP_001158232.1
DNAAF5
NM_017802.4
MANE Select
c.550C>Ap.Arg184Ser
missense
Exon 1 of 13NP_060272.3
PRKAR1B
NM_001164760.2
MANE Select
c.-83G>T
5_prime_UTR
Exon 1 of 11NP_001158232.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAR1B
ENST00000537384.6
TSL:5 MANE Select
c.-83G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 11ENSP00000440449.1
DNAAF5
ENST00000297440.11
TSL:1 MANE Select
c.550C>Ap.Arg184Ser
missense
Exon 1 of 13ENSP00000297440.6
PRKAR1B
ENST00000537384.6
TSL:5 MANE Select
c.-83G>T
5_prime_UTR
Exon 1 of 11ENSP00000440449.1

Frequencies

GnomAD3 genomes
AF:
0.000397
AC:
60
AN:
151112
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.000460
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000667
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000612
AC:
6
AN:
9798
AF XY:
0.000841
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00105
Gnomad OTH exome
AF:
0.00336
GnomAD4 exome
AF:
0.000668
AC:
784
AN:
1174212
Hom.:
1
Cov.:
31
AF XY:
0.000670
AC XY:
382
AN XY:
570512
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
23334
American (AMR)
AF:
0.000375
AC:
4
AN:
10660
Ashkenazi Jewish (ASJ)
AF:
0.0000622
AC:
1
AN:
16080
East Asian (EAS)
AF:
0.0000383
AC:
1
AN:
26088
South Asian (SAS)
AF:
0.000390
AC:
18
AN:
46114
European-Finnish (FIN)
AF:
0.0000371
AC:
1
AN:
26942
Middle Eastern (MID)
AF:
0.00188
AC:
6
AN:
3194
European-Non Finnish (NFE)
AF:
0.000746
AC:
727
AN:
974582
Other (OTH)
AF:
0.000551
AC:
26
AN:
47218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
40
80
121
161
201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000397
AC:
60
AN:
151220
Hom.:
0
Cov.:
32
AF XY:
0.000338
AC XY:
25
AN XY:
73870
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41442
American (AMR)
AF:
0.000460
AC:
7
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3444
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5124
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10450
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000668
AC:
45
AN:
67408
Other (OTH)
AF:
0.00
AC:
0
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000540
Hom.:
0
Bravo
AF:
0.000404

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:1Benign:1
Aug 10, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Sep 12, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 184 of the DNAAF5 protein (p.Arg184Ser). This variant is present in population databases (no rsID available, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with DNAAF5-related conditions. ClinVar contains an entry for this variant (Variation ID: 241208). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DNAAF5 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Primary ciliary dyskinesia 18 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Uncertain:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

Congenital heart disease Uncertain:1
Aug 12, 2020
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.77
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.41
CADD
Uncertain
25
DANN
Benign
0.94
DEOGEN2
Uncertain
0.59
D
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.85
D
M_CAP
Pathogenic
0.35
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.0
T
PhyloP100
1.6
PrimateAI
Pathogenic
0.94
D
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.10
Sift
Uncertain
0.0090
D
Sift4G
Uncertain
0.011
D
Polyphen
0.70
P
Vest4
0.38
MutPred
0.47
Loss of helix (P = 0.0237)
MVP
0.048
MPC
0.55
ClinPred
0.12
T
GERP RS
1.4
PromoterAI
0.013
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Varity_R
0.27
gMVP
0.64
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878855039; hg19: chr7-766907; API